Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients

BACKGROUND: Due to the waning humoral response after a two-dose SARS-CoV-2 mRNA vaccination, a third booster was recommended in hemodialyis patients. Data on a heterologous mRNA-vector regimen, which might improve immunogenicity, are very limited. METHODS: In this observational study 36 chronic hemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidovic, Tamara, Schimpf, Judith, Abbassi-Nik, Armin, Stockinger, Richard, Sprenger-Mähr, Hannelore, Lhotta, Karl, Zitt, Emanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261096/
https://www.ncbi.nlm.nih.gov/pubmed/35812459
http://dx.doi.org/10.3389/fimmu.2022.907615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261096/
https://www.ncbi.nlm.nih.gov/pubmed/35812459
http://dx.doi.org/10.3389/fimmu.2022.907615

Ejemplares similares